Cellular Health Screening Market - Growth, Trends, and Forecasts (2020 - 2025)
|出版商||Mordor Intelligence Pvt Ltd||商品編碼||921883|
|出版日期||內容資訊||英文 111 Pages
|全球細胞健康篩檢市場:成長，趨勢，及預測(2020年∼2025年) Cellular Health Screening Market - Growth, Trends, and Forecasts (2020 - 2025)|
|出版日期: 2020年06月01日||內容資訊: 英文 111 Pages||
The growth of the market is attributed to rising applications of cellular health screening in personalized medicine, and increasing government focus towards preventive healthcare. The potential applications of cellular health screening in personalized medicine have provided significant growth opportunities to market players in this field. According to a research study conducted by the University of Utah GSLC, researchers were able to achieve blocking of telomerase activity in prostate and breast cancer cells that were cultured in the laboratory resulting in the death of tumor cells. Therefore, these researches conducted by various institutes lead to a rise in the use of telomere test kits in cellular health screening and other application areas, which is expected to drive the cellular health screening market in the forecast period.
However, the risk associated with the transport of samples is expected to restrain the growth of the global market in the forecast period.
Single Test Panels Segment is Expected to Dominate the Market over the Forecasted Period
Based on type, the Cellular Health Screening market is segmented into single test panels and multi-test panels. single test panels segment is expected to dominate the market and accounts for a larger share of the cellular health screening market as these panels are used to get more accurate information and help in performing cellular health screening test to measure the length of the telomere, thereby preventing diseases. Furthermore, with the rising geriatric population, the preference of telomere tests is expected to rise as it facilitates individuals to check their cellular age and thereby take preventive measures, which contributes to the high growth of the cellular health screening market.
North America leads the Cellular Health Screening Market
North America leads the Cellular Health Screening Market owing to high patient pool and rising disease prevalence, followed by Europe. According to the National Cancer Institute, in 2018, there were 1,735,350 new cancer cases diagnosed in the United States. Furthermore, the growing cases of chronic diseases are expected to drive R&D of the companies and thus, healthcare providers are shifting towards better mode of disease screening. On the other hand, the high growth in the Asia Pacific is due to the rise in government initiatives for preventive healthcare. For instance, in 2018, the government of Australia invested USD 10 million in research with an aim to prevent diseases and promote better health choices. These initiatives will likely propel the growth of cellular health screening market.
Many of the global players are into the Cellular Health Screening Market. For instance - Bio-Reference Laboratories, Inc., Genova Diagnostics, Immundiagnostik AG, Quest Diagnostics, SpectraCell Laboratories, Inc., Telomere Diagnostics Inc. etc. are providing these products across the globe.